Cargando…

A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes

Metformin is the most often prescribed drug for people with type 2 diabetes (T2D). More than 120 million patients with T2D use metformin worldwide. However, monotherapy fails to achieve glycemic control in a third of the treated patients. Genetics contribute to some of the inter-individual variation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damanhouri, Zoheir A., Alkreathy, Huda M., Alharbi, Fawaz A., Abualhamail, Haneen, Ahmad, Muhammad S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812811/ https://www.ncbi.nlm.nih.gov/pubmed/36619226 http://dx.doi.org/10.7150/ijms.77206

Ejemplares similares

Bisoprolol responses (PK/PD) in hypertensive patients: A cytochrome P450 (CYP) 2D6 targeted polymorphism study
por: Mohammed Alkreathy, Huda, et al.
Publicado: (2020)

Comparative Biochemical and Histopathological Studies on the Efficacy of Metformin and Virgin Olive Oil against Streptozotocin-Induced Diabetes in Sprague-Dawley Rats
por: Balamash, Khadijah Saeed, et al.
Publicado: (2018)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals
por: Al-malky, Hamdan S., et al.
Publicado: (2019)

Catharanthus roseus Combined with Ursolic Acid Attenuates Streptozotocin-Induced Diabetes through Insulin Secretion and Glycogen Storage
por: Alkreathy, Huda Mohammed, et al.
Publicado: (2020)

Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients
por: Mousavi, Saeedeh, et al.
Publicado: (2017)

Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients
por: Ortega-Ayala, Adiel, et al.
Publicado: (2022)

A new gender-specific model for skin autofluorescence risk stratification
por: Ahmad, Muhammad S., et al.
Publicado: (2015)

Corrigendum: A new gender-specific model for skin autofluorescence risk stratification
por: Ahmad, Muhammad S., et al.
Publicado: (2017)

Pharmacogenetics Meets Metabolomics: Discovery of Tryptophan as a New Endogenous OCT2 Substrate Related to Metformin Disposition
por: Song, Im-Sook, et al.
Publicado: (2012)

Pharmacogenetics of Type 2 Diabetes—Progress and Prospects
por: Nasykhova, Yulia A., et al.
Publicado: (2020)

Pharmacogenetics and personalized treatment of type 2 diabetes
por: Semiz, Sabina, et al.
Publicado: (2013)

The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes
por: Walford, Geoffrey A., et al.
Publicado: (2015)

Effects of Methanolic Extract Based-Gel From Saudi Pomegranate Peels With Enhanced Healing Potential on Excision Wounds in Diabetic Rats
por: Karim, Shahid, et al.
Publicado: (2021)

Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients
por: Elalem, Elbatool G., et al.
Publicado: (2022)

The Pharmacogenetics of Type 2 Diabetes: A Systematic Review
por: Maruthur, Nisa M., et al.
Publicado: (2014)

Secretion of Mast Cell Inflammatory Mediators Is Enhanced by CADM1-Dependent Adhesion to Sensory Neurons
por: Magadmi, Rania, et al.
Publicado: (2019)

Pharmacogenetics in type 2 diabetes: potential implications for clinical practice
por: Huang, Chunmei, et al.
Publicado: (2011)

Pharmacogenetics of Anti-Diabetes Drugs
por: DiStefano, Johanna K., et al.
Publicado: (2010)

Ethnicity and skin autofluorescence-based risk-engines for cardiovascular disease and diabetes mellitus
por: Ahmad, Muhammad Saeed, et al.
Publicado: (2017)

The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study
por: Altmaier, Elisabeth, et al.
Publicado: (2016)

Tetramethylpyrazine ameliorates indomethacin-induced gastric ulcer in rats: Impact on oxidative, inflammatory, and angiogenic machineries
por: AlKreathy, Huda M., et al.
Publicado: (2020)

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
por: Israel, Marc K, et al.
Publicado: (2008)

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
por: DeFronzo, Ralph A., et al.
Publicado: (2009)

Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents
por: Dawed, Adem Yesuf, et al.
Publicado: (2016)

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine
por: Mannino, Gaia Chiara, et al.
Publicado: (2019)

Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
por: Al Omari, Mousa, et al.
Publicado: (2016)

Comparison of Safety and Efficacy of Glimepiride-Metformin and Vildagliptin- Metformin Treatment in Newly Diagnosed Type 2 Diabetic Patients
por: Kumar, Surendra
Publicado: (2021)

Lycorine Ameliorates Thioacetamide-Induced Hepatic Fibrosis in Rats: Emphasis on Antioxidant, Anti-Inflammatory, and STAT3 Inhibition Effects
por: Alkreathy, Huda Mohammed, et al.
Publicado: (2022)

Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study
por: Melaibari, Maryam, et al.
Publicado: (2023)

Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination
por: Dong, Yu, et al.
Publicado: (2016)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

Green Silver Nanoparticles Synthesized from Taverniera couneifolia Elicits Effective Anti-Diabetic Effect in Alloxan-Induced Diabetic Wistar Rats
por: Ul Haq, Muhammad Nisar, et al.
Publicado: (2022)

Effect of Metformin on Doxorubicin-Induced Memory Dysfunction
por: Alharbi, Ibrahim, et al.
Publicado: (2020)

Efficacy of computational predictions of the functional effect of idiosyncratic pharmacogenetic variants
por: McConnell, Hannah, et al.
Publicado: (2021)

Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis
por: Condreay, Lynn D., et al.
Publicado: (2020)

Obesity Connected Metabolic Changes in Type 2 Diabetic Patients Treated With Metformin
por: Aleidi, Shereen M., et al.
Publicado: (2021)

Development of response surface methodology for optimization of extraction parameters and quantitative estimation of embelin from Embelia ribes Burm by high performance liquid chromatography
por: Alam, Md. Shamsir, et al.
Publicado: (2015)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_95edslprh87l90qgn6l0umv6q3